• No fasting is required for this test. You may eat and drink normally unless advised otherwise.
• Inform the laboratory team about any ongoing treatments, especially chemotherapy, radiation therapy, or medications affecting the liver or pancreas.
• Share your medical history, including any previous diagnosis of cancer or gastrointestinal disease.
• Avoid strenuous physical activity immediately before sample collection.
• Carry your doctor’s prescription and a valid ID proof at the time of testing.
• For follow-up monitoring, it is advisable to use the same laboratory for consistency in results.

The CA 19-9 test measures the level of a specific protein that may be produced by cancer cells, particularly those originating in the pancreas, liver, gallbladder, or bile ducts. Elevated levels of CA 19-9 are most commonly associated with pancreatic cancer but can also be seen in other gastrointestinal malignancies.

Doctors commonly recommend the CA 19-9 test to:

• Monitor pancreatic and gastrointestinal cancers
• Evaluate response to cancer treatment
• Detect recurrence after treatment
• Support diagnosis in combination with imaging and other tests
• Assess disease progression in advanced cases

The test involves collecting a small blood sample from a vein in the arm. The procedure is quick, safe, and minimally uncomfortable. Results are interpreted based on trends over time rather than a single value, as changes in CA 19-9 levels provide more meaningful clinical information.

It is important to note that elevated CA 19-9 levels do not always indicate cancer. Non-cancerous conditions such as pancreatitis, liver disease, or bile duct obstruction may also cause increased levels. Therefore, results are always evaluated in the context of clinical symptoms and additional investigations.